- Lobbying
- Bryant AND Hall
Lobbying Arrangements Results for 'Bryant Hall'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169). |
Takeda Pharmaceuticals America, Inc.
|
Tiber Creek Group | |||
Details Issues related to intellectual property protections for COVID-19 vaccines and treatments. Issues related to implementation of drug pricing and reimbursement for prescription drugs in the Inflation ... |
Gilead Sciences, Inc.
|
Tiber Creek Group | |||
Details Issues related to oncology care, physician reimbursement, and the cost of prescription drugs; Implementation of Inflation Reduction Act of 2022 (PL 117-169); H.R. 5378 - Lower Costs, More Transpare... |
Association for Clinical Oncology
|
Tiber Creek Group | |||
Details Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169). Issues related to sickle cell treatment. |
Tiber Creek Group (On behalf of Vertex Pharmaceuticals)
|
Tiber Creek Health Strategies, Inc. | |||
Details Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169); Issues related to women's health; Issues related to IP pro... |
Astellas Pharma US, Inc.
|
Tiber Creek Group | |||
Details Issues related to implementation of drug pricing and reimbursement of prescription drugs provision in The Inflation Reduction Act of 2022 (PL 117-169); issues relating to Medicare Part D and Part B... |
Alnylam Pharmaceuticals, Inc.
|
Tiber Creek Group | |||
Details H.R. 5388/S. 2740 - PREPARE Act of 2021, issues relating to Domestic API production. |
Phlow Corporation
|
Tiber Creek Group | |||
Details Issues related to FDA, Medicare reimbursement, cancer screening, workforce shortages and artificial intelligence. |
Siemens Healthineers
|
Tiber Creek Group | |||
Details Issues related to opioid abuse prevention, H.R. 1185 - Opioid Patients Right to Know Act of 2021. |
Prevent Opioid Abuse
|
Tiber Creek Group | |||
Details Issues related to implementation of drug pricing and reimbursement for prescription drugs in Inflation Reduction Act of 2022 (PL 117-169); Issues related to FDA, Consolidated Appropriations Act, 20... |
BeiGene USA, Inc.
|
Tiber Creek Group | |||
Details Issues related to drug pricing and reimbursement for prescription drugs, Issues related to implementation of the Inflation Reduction Act of 2022 (PL 117-169). Issues relating to drug pricing; Issue... |
Tiber Creek Health Strategies, Inc. (on behalf of Eli Lilly and Company)
|
Tiber Creek Group | |||
Details Issues related to the tax treatment of motorsports entertainment complexes; H.R.2696/S.2462, Motorsports Fairness and Permanency Act of 2023. |
ACCUS
|
OGR (formerly known as Ogilvy Government Relations) | |||
Details Issues related to antimicrobial resistance. H.R. 2940/S. 1355 - The PASTEUR Act. Issues related to the importation of non-human primates. |
Biotechnology Innovation Organization (BIO)
|
Tiber Creek Group | |||
Details Issues related to implementation of drug pricing and reimbursement for prescription drugs provision in Inflation Reduction Act of 2022 (PL 117-169); Issues related to Medicare Part D drug rebates; ... |
Amgen, Inc.
|
Tiber Creek Group | |||
Details Proposals that impact Medicare Part D. Ongoing implementation of payment and regulatory issues for the Medicare Advantage program. Issues related to H.R. 7839 Continuing Access to In Home IVIG Act.... |
Cigna Corporation
|
Tiber Creek | |||
Details H.R. 4368: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2024 H.R. 5893: Commerce, Justice, Science, and Related Agencies Appropriations Act... |
Pharmaceutical Research and Manufacturers of America
|
in-house lobbying |